Benzimidazole C-2 heterocycles as kinase inhibitors
US7312215B2 · kind B2 · utility
0Cited by
2References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 20, 2004 |
| Grant date | Dec 25, 2007 |
| Priority date | — |
| Expiry date | Jan 6, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Benzimidazole derivatives having the general formula Iare provided. These compounds are useful as tyrosine kinase inhibitors, especially for the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.